Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients (Q73082058)
Jump to navigation
Jump to search
scientific article published on 01 March 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients |
scientific article published on 01 March 1997 |
Statements
Both resting and activated B lymphocytes expressing engineered peptide-Ig molecules serve as highly efficient tolerogenic vehicles in immunocompetent adult recipients (English)
E T Zambidis
R K Barth